Company Novo Nordisk Farma Srl with Fiscal Code 17355938
recorded a turnover of 2024 of
272.677.883,
with a net profit of
6.841.493
and having an average number of employees of
108.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Novo Nordisk Farma Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
4.452.270
4.755.459
4.957.957
5.894.578
21.091.246
58.372.910
91.258.097
137.005.778
209.998.616
272.677.883
Total Income - EUR
4.481.481
4.774.020
4.980.616
5.910.538
21.124.957
58.445.271
92.104.411
137.024.855
210.006.638
272.679.320
Total Expenses - EUR
4.304.376
4.543.511
4.749.777
5.711.320
20.536.897
56.951.205
89.847.757
132.268.996
202.756.132
263.276.251
Gross Profit/Loss - EUR
177.105
230.509
230.839
199.218
588.060
1.494.066
2.256.655
4.755.859
7.250.506
9.403.069
Net Profit/Loss - EUR
23.272
75.841
109.643
61.095
119.664
1.419.740
1.812.892
4.079.621
6.111.573
6.841.493
Employees
42
40
43
48
54
56
67
92
102
108
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 30.6%, from 209.998.616 euro in the year 2023, to 272.677.883 euro in 2024.
The Net Profit increased by 764.076 euro, from 6.111.573 euro in 2023, to 6.841.493 in the last year.
Check the financial reports for the company - Novo Nordisk Farma Srl
Financial Rating - NOVO NORDISK FARMA SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Novo Nordisk Farma Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Novo Nordisk Farma Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Novo Nordisk Farma Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Novo Nordisk Farma Srl - CUI 17355938
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
52.315
49.058
69.388
76.022
77.206
116.039
413.649
696.048
686.955
568.576
Current Assets
1.409.440
1.551.623
1.734.435
1.665.426
27.450.304
54.872.288
56.045.853
83.963.514
131.828.101
163.678.955
Inventories
0
0
0
0
10.161.150
28.767.975
19.834.041
20.387.551
44.149.459
60.284.151
Receivables
1.281.608
1.220.637
1.472.578
1.481.977
15.982.907
23.548.662
35.409.074
61.454.215
87.060.052
98.572.796
Cash
127.833
330.986
261.857
183.449
1.306.247
2.555.650
802.739
2.121.748
618.590
4.822.008
Shareholders Funds
1.132.604
1.196.894
1.286.284
1.323.773
1.417.801
7.565.578
9.210.696
33.596.699
39.606.393
127.409.023
Social Capital
628.796
622.384
611.852
600.623
588.991
5.332.741
5.214.482
25.508.466
25.431.113
25.288.987
Debts
350.145
414.044
580.953
444.973
25.785.316
47.437.705
47.260.045
51.153.879
92.849.021
36.751.141
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
163.678.955 euro in 2024 which includes Inventories of
60.284.151 euro, Receivables of
98.572.796 euro and cash availability of
4.822.008 euro.
The company's Equity was valued at
127.409.023 euro, while total Liabilities amounted to
36.751.141 euro.
Equity increased by 88.023.980 euro, from 39.606.393 euro in 2023, to 127.409.023 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novo Nordisk Farma Srl